A retrospective chart review to investigate clinical remission in patients with severe asthma treated with biologics in the United Kingdom National Health Service

Trial Identifier:	D2287R00189
Sponsor:	AstraZeneca
NCTID::	NCT06261567
Start Date:	February 2024
Primary Completion Date:	September 2024
Study Completion Date:	September 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
UK	Birmingham, UK
UK	London, UK
UK	Manchester, UK
UK	Southampton, UK

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.